Diagnosis and management of somatosensory tinnitus: review article

Tanit Ganz Sanchez, Carina Bezerra Rocha, Tanit Ganz Sanchez, Carina Bezerra Rocha

Abstract

Tinnitus is the perception of sound in the absence of an acoustic external stimulus. It affects 10-17% of the world's population and it a complex symptom with multiple causes, which is influenced by pathways other than the auditory one. Recently, it has been observed that tinnitus may be provoked or modulated by stimulation arising from the somatosensorial system, as well as from the somatomotor and visual-motor systems. This specific subgroup -somatosensory tinnitus - is present in 65% of cases, even though it tends to be underdiagnosed. As a consequence, it is necessary to establish evaluation protocols and specific treatments focusing on both the auditory pathway and the musculoskeletal system.

References

    1. Jastreboff PJ, Sasaki CT. An animal model of tinnitus: a decade of development. Am J Otol. 1994;15:9–11.
    1. Seidman MD, Jacobson GP. Update on tinnitus. Otolaryngol Clin North Am. 1996;29:455–65.
    1. Lockwood AH, Salvi RJ, Burkard RF, Galantowicz PJ, Coad ML, Wack DS. Neuroanatomy of tinnitus. Scand Audiol. 1999;28:47–52.
    1. Levine RA. Somatic Modulation appears to be a fundamental attribute of tinntus. In: Hazell J P W, editor. Proceedings of the Sixth International Tinnitus Seminar. London: The Tinnitus and Hyperacusis Center; 1999. pp. 193–7. editor.
    1. Sanchez TG, Guerra GCY, Lorenzi MC, Brandão AL, Bento RF. The influence of voluntary muscle contractions upon the onset and modulation of tinnitus. Audiol Neurootol. 2002;7:370–5.
    1. Sanchez TG, Lima AS, Brandao AL, Lorenzi MC, Bento RF. Somatic modulation of tinnitus: test reliability and results after repetitive muscle contraction training. Ann Otol. 2007;116:30–5.
    1. Coad ML, Lockwood A, Salvi R, Burkard R. Characteristics of patients with gaze-evoked tinnitus. Otol Neurotol. 2001;22:650–4.
    1. Baguley DM, Phillips J, Humphriss RL, Jones S, Axon PR, Moffat DA. The prevalence and onset of gaze modulation of tinnitus and increased sensitivity to noise after translabyrinthine vestibular schwannoma excision. Otol Neurotol. 2006;27:220–4.
    1. Sanchez TG, Pio MRB. Abolição de zumbido evocado pela movimentação ocular por meio de repetição do deslocamento do olhar: um método inovador. Arq Otorhinolaryngol. 2007;11:451–3.
    1. Rocha CACB, Sanchez TG. Myofascial trigger points: another way of modulating tinnitus. Prog Brain Res. 2007;166:209–14.
    1. Rocha CACB, Sanchez TG, Siqueira JTT. Myofascial trigger points: a possible way of modulating tinnitus. Audiol Neurootol. 2008;13:153–60.
    1. Cacace AT, Cousins JP, Parnes SM, McFarland DJ, Semenoff D, Holmes T, et al. Cutaneous-evoked tinnitus. II. Review of neuroanatomical, physiological and functional imaging studies. Audiol Neurootol. 1999;4:247–57.
    1. Sanchez TG, Marcondes RA, Kii MA, Lima AS, Rocha CAB, Ono CR, et al. A different case of tinnitus modulation by tactile stimuli in a patient with pulsatile tinnitus. Presented at the Second Meeting of the Tinnitus Research Initiative, Monaco. 2007:21–3.
    1. Møller AR, Rollins PR. The non-classical auditory pathways are involved in hearing in children but not in adults. Neurosci Lett. 2002;319:41–4.
    1. Cullington H. Tinnitus evoked by finger movement: brain plasticity after peripheral deafferentation. Neurology. 2001;56:978.
    1. Pinchoff RJ, Burkard RF, Salvi RJ, Coad ML, Lockwood AH. Modulation of tinnitus by voluntary jaw movements. Am J Otol. 1998;19:785–9.
    1. Wright DD, Ryugo DK. Mossy fiber projections from the cuneate nucleus to the cochlear nucleus in the rat. J Comp Neurol. 1996;365:159–72.
    1. Shore S, Zhou J, Koehler S. Neural mechanisms underlying somatic tinnitus. Prog Brain Res. 2007;166:107–23.
    1. Young ED, Nelken I, Conley RA. Somatosensory effects on neurons in dorsal cochlear nucleus. J Neurophysiol. 1995;73:743–65.
    1. Wright DD, Ryugo DK. Mossy fiber projections from the cuneate nucleus to the cochlear nucleus in the rat. J Comp Neurol. 1996;365:159–72.
    1. Levine RA. Somatic (craniocervical) tinnitus and the dorsal cochlear nucleus hypothesis. Am J Otolaryngol. 1999;20:351–62.
    1. Aitkin LM, Irvine DR, Nelson JE, Merzenich MM, Clarey JC. Frequency representation in the auditory midbrain and forebrain of a marsupial, the northern native cat (Dasyurus hallucatus) Brain Behav Evol. 1986;29:17–28.
    1. Møller AR, Møller MB, Yokota M. Some forms of tinnitus may involve the extralemniscal auditory pathway. Laryngoscope. 1992;102:1165–71.
    1. Cacace AT. Expanding the biological basis of tinnitus: crossmodal origins and the role of neuroplasticity. Hear Res. 2003;175:112–32.
    1. Chen R, Cohen LG, Hallett M. Nervous system reorganization following injury. Neuroscience. 2002;111:761–73.
    1. Sanchez TG, Kii MA. Modulating tinnitus with visual, muscular and tactile stimulation. Seminars in Hearing, Tinnitus: part II. 2008;29:350–60.
    1. Sanchez TG, Rocha CACB. Patients with normal hearing and chronic pain experience more relief from tinnitus when subject to deactivation of myofascial trigger points. In: XXXI International Congress of Audiology 2010, São Paulo.
    1. Sanchez TG. What to expect from your physician and other healthcare professionals. In: Tyler R, editor. The Consumer Handbook on Tinnitus. Sedona: Auricle Ink Publishers; 2008. p. 183. editor.
    1. Björne A. Assessment of temporomandibular and cervical spine disorders in tinnitus patients. Prog Brain Res. 2007;166:215–9.
    1. Felício CM, Melchior MO, Ferreira CL, Silva MA. Otologic symptoms of temporomandibular disorder and effect of orofacial myofunctional therapy. Cranio. 2008;26:118–25.
    1. Wright EF, Bifano SL. Tinnitus improvement through TMD therapy. J Am Dent Assoc. 1997;128:1424–32.
    1. Kessinger RC, Boneva DV. Vertigo, tinnitus, and hearing loss in the geriatric patient. J Manipulative Physiol Ther. 2000;23:352–62.
    1. Kessinger RC, Boneva DV. Case study: acceleration/deceleration injury with angular kyphosis. J Manipulative Physiol Ther. 2000;23:279–87.
    1. Alcantara J, Plaugher G, Klemp DD, Salem C. Chiropractic care of a patient with temporomandibular disorder and atlas subluxation. J Manipulative Physiol Ther. 2002;25:63–70.
    1. Leboeuf-Yde C, Pedersen EN, Bryner P, Cosman D, Hayek R, Meeker WC, et al. Self-reported nonmusculoskeletal responses to chiropractic intervention: a multination survey. J Manipulative Physiol Ther. 2005;28:294–302.
    1. DeVocht JW, Schaeffer W, Lawrence DJ. Chiropractic treatment of temporomandibular disorders using the activator adjusting instrument and protocol. Altern Ther Health Med. 2005;11:70–3.
    1. Kaute BB. The influence of Atlas therapy on tinnitus. Int Tinnitus J. 1998;4:165–7.
    1. Travell J. Temporomandibular joint pain referred from muscle of the head and neck. J Prosthet Dent. 1960;10:745–63.
    1. Wyant GM. Chronic pain syndromes and their treatment. II. Trigger points. Canad Anaesth Soc J. 1979;26:216–9.
    1. Estola-Partanen M. Muscular tension and tinnitus: an experimental trial of trigger point injections on tinnitus (dissertation) 2000 Tampere, University of Tampere.
    1. Eriksson M, Gustafsson S, Axelsson A. Tinnitus and trigger points: a randomized cross-over study. In: Reich G E, Vernon J A, editors. Proceedings of the Fifth International Tinnitus Seminar. Portland: 1995. pp. 81–3.
    1. Rocha CACB, Sanchez TG. 2007. Tinnitus modulation by miofascial trigger points and its disappearance by treatment of the myofascial pain syndrome: an interesting result; p. 49. In: Langguth B. Abstracts of the Second Meeting of Tinnitus Research Initiative, Monaco, 2007. Univ. of Regensburg.
    1. Rocha CACB. São Paulo: Universidade de São Paulo; 2010. Eficácia da Desativação dos Pontos-gatilho Miofasciais para o Tratamento do Zumbido em Pacientes com Síndrome Dolorosa Miofascial.
    1. Vernon H, Schneider M. Chiropractic management of myofascial trigger points and myofascial pain syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009;32:14–24.
    1. Vaynman S, Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured CNS by using neurotrophins. Neurorehabil Neural Repair. 2005;19:283–95.
    1. Sanchez TG, Lima AS, Brandão AL, Lorenzi MC, Bento RF. Somatic modulation of tinnitus: test reliability and results after repetitive muscle contraction training. Ann Otol Rhinol Laryngol. 2007;116:30–5.
    1. Sanchez TG, Pio MRB. Abolição de zumbido evocado pela movimentação ocular por meio da repetição do deslocamento do olhar: um método inovador. Arq Int Otorrinolaringol. 2007;11:345–9.
    1. Kaada B, Hognestad S, Havstad J. Transcutaneous nerve stimulation (TNS) in tinnitus. Scand Audiol. 1989;18:211–7.
    1. Rahko T, Kotti V. Tinnitus treatment by transcutaneous nerve stimulation (TNS) Acta Otolaryngol Suppl. 1997;529:88–9.
    1. Aydemir G, Tezer MS, Borman P, Bodur H, Unal A. Treatment of tinnitus with transcutaneous electrical nerve stimulation improves patients' quality of life. J Laryngol Otol. 2006;120:442–5.
    1. Attias J, Shemesh Z, Sohmer H, Gold S, Shoham C, Faraggi D. A comparison between self-hypnosis, masking and attentiveness for alleviation of chronic tinnitus. Audiology. 1993;32:205–12.
    1. Marks NJ, Karl H, Onisiphorou CA. controlled trial of hypnotherapy in tinnitus. Clin Otolaryngol Allied Sci. 1985;10:43–6.
    1. Coles RRA, Hallam RS. Tinnitus and its management. Br Med Bull. 1987;43:983–98.
    1. Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev. 1981;33:155–88.
    1. Blersch W, Schulte-Mattler WJ, Przywara S, May A, Bigalke H, Wohlfarth K. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci. 2002;205:59–63.
    1. Dolly O. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. Headache. 2003;43:16–24.
    1. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26:785–93.
    1. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107:125–33.
    1. Durham PL, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44:35–42.
    1. Oshinsky M, Poso-Rosich P, Luo J, Hyman S, Silberstein SD. Botulinum toxin A blocks sensitization of neurons in the trigeminal nucleus caudalis. Cephalalgia. 2004;24:781.
    1. Stidham KR, Solomon PH, Roberson JB. Evaluation of botulinum toxin A in treatment of tinnitus. Otolaryngol Head Neck Surg. 2005;132:883–9.
    1. Láinez MJ, Piera A. Botulinum toxin for the treatment of somatic tinnitus. Prog Brain Res. 2007;166:335–8.
    1. Girlanda P, Vita G, Nicolosi C, Milone S, Messina C. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry. 1992;55:844–5.
    1. Marion MH. Hemifacial spasm: treatment with botulinum toxin (long term results) In: Sindou M, Keravel Y, Møller A R, editors. Hemifacial Spasm. A Multidisiplinary Approach. Springer: Wien; 1997. pp. 141–4.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir